Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
43,543,534
-
Share change
-
-5,531,774
-
Total reported value
-
$1,499,962,663
-
Put/Call ratio
-
279%
-
Price per share
-
$34.45
-
Number of holders
-
180
-
Value change
-
+$140,947,867
-
Number of buys
-
107
-
Number of sells
-
108
Institutional Holders of AIMMUNE THERAPEUTICS INC - COM (AIMT) as of Q3 2020
As of 30 Sep 2020 AIMMUNE THERAPEUTICS INC - COM (AIMT) had 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,543,534 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Pentwater Capital Management LP, GOLDMAN SACHS GROUP INC, ALPINE ASSOCIATES MANAGEMENT INC., STATE STREET CORP, Magnetar Financial LLC, GABELLI FUNDS LLC, WATER ISLAND CAPITAL LLC, and JPMORGAN CHASE & CO.
This table shows 180 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.